Skip to content
healthcare.dev
Get a free key

Lamivudine

NDC 50742-623, Lamivudine, tablet, from Ingenus Pharmaceuticals, LLC.

Product NDC
50742-623
Status
Listed
Labeler
Ingenus Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206974
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50742-623 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
50742-623-605074206236060 TABLET in 1 BOTTLE, PLASTIC (50742-623-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/47f8be59-178c-4bad-96a4-a5c82784f308

Use it

Look up 50742-623 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50742-623 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50742-623. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.